pramipexole has been researched along with Addiction, Opioid in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 2 (66.67) | 2.80 |
Authors | Studies |
---|---|
Escalona, R; Laubenthal, CE; Welch, JE | 1 |
Escalona, R; Fawcett, J; Rush, AJ | 1 |
Caine, SB; Everitt, BJ; Koob, GF; Parsons, LH; Schwartz, JC; Sokoloff, P | 1 |
3 other study(ies) available for pramipexole and Addiction, Opioid
Article | Year |
---|---|
Rapid Treatment of Anhedonia With Pramipexole as Adjunct to Buprenorphine in Opioid Use Disorder.
Topics: Anhedonia; Buprenorphine; Humans; Narcotic Antagonists; Opioid-Related Disorders; Pramipexole | 2023 |
Pramipexole Augmentation of Buprenorphine Improves Pain and Depression in Opioid Use Disorder: A Case Report.
Topics: Analgesics, Opioid; Buprenorphine; Depression; Humans; Opioid-Related Disorders; Pain; Pramipexole | 2020 |
D3 receptor test in vitro predicts decreased cocaine self-administration in rats.
Topics: Animals; Benzopyrans; Benzothiazoles; Cocaine; Dopamine Agonists; Dopamine Antagonists; In Vitro Techniques; Male; Naphthalenes; Opioid-Related Disorders; Oxazines; Pramipexole; Pyrrolidines; Quinolines; Rats; Receptors, Dopamine D2; Receptors, Dopamine D3; Self Administration; Thiazoles | 1997 |